Decades of History Tell Anything: Biotech Near $50 Set to Soar
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Investors needing highly customized portfolios or personal financial planning may prefer traditional advisory services over automated solutions.
24,498 articlesA cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Natera shows growth through AI-enabled cell-free DNA tests and a widening data moat, positioning it as a leading nate...
Brookfield is pursuing corporate simplification by merging its insurance arm with the parent company. This move could...
A top AI analyst argues the AI revolution is still in its early stages, with ASML’s hefty backlog and robust Q1 2026 ...
Vertex Pharmaceuticals is being pitched as a durable cash-flow king for patient investors. This piece analyzes the ca...
A weekend meteor over New England, described as elephant-sized by NASA, created loud booms and sparked a fresh look a...
The S&P 500 will initially exclude spacex from the index as the committee prepares for an August rebalance. Elon Musk...
Arthur Hayes faces swift backlash after signaling bullish bets on several coins, only to exit large positions soon af...
Bitcoin whipped between gains and losses as geopolitical tensions intensified. A bold move by Strategy to add to BTC ...
Energy refuses quit: stocks keep leading gains into June 2026, with the XLE ETF rising and major oil names driving th...
Inflation data for May shows a 4.2% year-over-year rise, sparking notable moves in bitcoin (btc) price moves. Traders...
American Water Works raised its quarterly dividend by 8% to $0.895 per share, a move funded by regulator-approved rat...